ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Antimetabolites ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors 14 coordinate concepts ∟ Aromatase Inhibitors \| ∟ Carbonic Anhydrase Inhibitors \| ∟ Cholinesterase Inhibitors \| ∟ Cyclooxygenase Inhibitors \| ∟ Folic Acid Antagonists \| ∟ Integrase Inhibitors \| ∟ Lipoxygenase Inhibitors \| ∟ Monoamine Oxidase Inhibitors \| ∟ Nucleic Acid Synthesis Inhibitors \| ∟ Phosphodiesterase Inhibitors \| ∟ Protease Inhibitors \| ∟ Protein Kinase Inhibitors \| ∟ Protein Synthesis Inhibitors \| ∟ Uncoupling Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Enzyme Inhibitors ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors 14 coordinate concepts ∟ Aromatase Inhibitors \| ∟ Carbonic Anhydrase Inhibitors \| ∟ Cholinesterase Inhibitors \| ∟ Cyclooxygenase Inhibitors \| ∟ Folic Acid Antagonists \| ∟ Integrase Inhibitors \| ∟ Lipoxygenase Inhibitors \| ∟ Monoamine Oxidase Inhibitors \| ∟ Nucleic Acid Synthesis Inhibitors \| ∟ Phosphodiesterase Inhibitors \| ∟ Protease Inhibitors \| ∟ Protein Kinase Inhibitors \| ∟ Protein Synthesis Inhibitors \| ∟ Uncoupling Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors 14 coordinate concepts ∟ Aromatase Inhibitors \| ∟ Carbonic Anhydrase Inhibitors \| ∟ Cholinesterase Inhibitors \| ∟ Cyclooxygenase Inhibitors \| ∟ Folic Acid Antagonists \| ∟ Integrase Inhibitors \| ∟ Lipoxygenase Inhibitors \| ∟ Monoamine Oxidase Inhibitors \| ∟ Nucleic Acid Synthesis Inhibitors \| ∟ Phosphodiesterase Inhibitors \| ∟ Protease Inhibitors \| ∟ Protein Kinase Inhibitors \| ∟ Protein Synthesis Inhibitors \| ∟ Uncoupling Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Toxic Actions ∟ Noxae ∟ Antimetabolites ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors 14 coordinate concepts ∟ Aromatase Inhibitors \| ∟ Carbonic Anhydrase Inhibitors \| ∟ Cholinesterase Inhibitors \| ∟ Cyclooxygenase Inhibitors \| ∟ Folic Acid Antagonists \| ∟ Integrase Inhibitors \| ∟ Lipoxygenase Inhibitors \| ∟ Monoamine Oxidase Inhibitors \| ∟ Nucleic Acid Synthesis Inhibitors \| ∟ Phosphodiesterase Inhibitors \| ∟ Protease Inhibitors \| ∟ Protein Kinase Inhibitors \| ∟ Protein Synthesis Inhibitors \| ∟ Uncoupling Agents X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Antimetabolites ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Enzyme Inhibitors ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Toxic Actions ∟ Noxae ∟ Antimetabolites ∟ Antilipemic Agents ∟ Anticholesteremic Agents ∟ Hydroxymethylglutaryl-CoA Reductase Inhibitors Anticholesteremic Agents > Antilipemic Agents > Antimetabolites > Molecular Mechanisms of Action > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Enzyme Inhibitors > Molecular Mechanisms of Action > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Anticholesteremic Agents > Antilipemic Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Anticholesteremic Agents > Antilipemic Agents > Antimetabolites > Noxae > Toxic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Annotation:	X ref STATINS, HMG-COA: do not confuse with statin protein in SCR X
History note:	Enzyme Inhibitors (1976-1996) \| Hydroxymethylglutaryl CoA Reductases/antagonists & inhibitors (1976-1996)X
historyNote*:	98 X
publicMeSHNote*:	98; see HMG-COA REDUCTASE INHIBITORS 1997; for HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS see HMG-COA REDUCTASE INHIBITORS 1997 X
Scope note:	Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. X
activeMeSHYear*:	2004 \| 2005 \| 2006 \| 2006A \| 2007X
dateCreated*:	1996-06-10X
dateEstablished*:	1997-01-01X
dateRevised*:	2005-08-01X
recordAuthorizer*:	agsX
recordMaintainer*:	agsX
recordOriginator*:	TPWX
Related term:	Hydroxymethylglutaryl CoA Reductases X
Type:	Concept X
Coordinate terms:	Aromatase Inhibitors \| Carbonic Anhydrase Inhibitors \| Cholinesterase Inhibitors \| Cyclooxygenase Inhibitors \| Folic Acid Antagonists \| Integrase Inhibitors \| Lipoxygenase Inhibitors \| Monoamine Oxidase Inhibitors \| Nucleic Acid Synthesis Inhibitors \| Phosphodiesterase Inhibitors \| Protease Inhibitors \| Protein Kinase Inhibitors \| Protein Synthesis Inhibitors \| Uncoupling Agents X
URI:	X
Labels and equivalent concepts:	Hydroksimetyyliglutaryyli-KoA-reduktaasin estäjät (fi) Hydroksimetyyliglutaryyli-KoA-reduktaasin inhibiittori (fi, replaced) Hydroksimetyyliglutaryyli-KoA-reduktaasin inhibiittorit (fi, replaced) Statiini (fi, replaced) Statiinit (fi, replaced) Hydroksimetyyliglutaryyli-KoA-reduktaasin estäjä (fi, replaced) Hydroximetylglutaryl CoA-reduktashämmare (sv) Statins, HMG-CoA (en, replaced) Inhibitors, HMG-CoA Reductase (en, replaced) Inhibitors, Hydroxymethylglutaryl-CoA (en, replaced) Inhibitors, Hydroxymethylglutaryl-Coenzyme A (en, replaced) HMG-CoA Reductase Inhibitors (en, replaced) X
Share:	X